American Healthcare REIT, Inc.
AHR
Rang în acțiuni
#1815
American Healthcare REIT (AHR) was forged through a significant strategic... American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated management platform, staffed by over one hundred highly experienced and proficient professionals. Many members of this team have a long history of collaboration, dating back to 2006, and have successfully invested in and overseen healthcare real estate assets across diverse market cycles. Their collective expertise, extensive industry network, and deep, firsthand understanding of each property within the international portfolio – which they have meticulously built and managed since its first acquisition in 2014 – are unparalleled. This powerful combination of a robust management team and a high-quality asset base strategically positions American Healthcare REIT to capitalize on compelling growth opportunities, driven by significant demographic trends. Its expansive portfolio encompasses 19 million square feet across 312 distinct properties, including medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. This diverse collection is strategically distributed across 36 U.S. states and the United Kingdom. The aforementioned tri-party transaction represented a pivotal step in ideally preparing American Healthcare REIT for a future public listing or Initial Public Offering (IPO) on a national stock exchange when market conditions are most favorable. By eventually listing its shares, the company anticipates gaining enhanced access to attractive capital sources, which will be crucial for fueling future expansion, diversifying its investor base, and providing greater liquidity for its existing stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
Preț acțiune
$54.20
Ultima sincronizare: 2026-10-20
Capitalizare de piață
$11.79B
Schimbare (1 zi)
3.19%
Schimbare (1 an)
28.76%
Țară
US
Tranzacționează American Healthcare REIT, Inc. (AHR)
Categorie
Real Estate
Raport P/E pentru American Healthcare REIT, Inc. (AHR)
Raport P/E la data de October 2026 TTM: 77.01
Conform celor mai recente rapoarte financiare și prețului acțiunilor American Healthcare REIT, Inc., raportul P/E actual (TTM) este 77.01. La sfârșitul anului 2023, compania avea un P/E de -12.22.
Istoricul raportului P/E pentru American Healthcare REIT, Inc. din 2016 până în 2026
Raportul P/E la sfârșitul fiecărui an
| An | Raport P/E | Schimbă |
|---|---|---|
| 2026 (TTM) | 77.01 | -178.43% |
| 2024 | -98.19 | 703.70% |
| 2023 | -12.22 | 13.48% |
| 2022 | -10.77 | -41.21% |
| 2021 | -18.31 | -104.54% |
| 2020 | 403.67 | -433.33% |
| 2019 | -121.10 | -343.68% |
| 2018 | 49.70 | -14.87% |
| 2017 | 58.38 | -1,428.35% |
| 2016 | -4.40 | 0.00% |
Raportul P/E pentru companii similare sau concurenți
| Companie | P/E Ratio | Diferență P/E Ratio | Țara |
|---|---|---|---|
| 120.30 | 56.21% |
US
|
|
| 153.29 | 99.06% |
US
|
|
| 15.60 | -79.74% |
US
|
|
| 53.54 | -30.47% |
US
|
|
| - | - |
US
|
Cum interpretezi un P/E ratio?
Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.
Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.
Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.